Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
animal testing
CRO
Charles River launches strategic review, shakes up board
The review comes as the CRO's revenue declined 1.8% year over year in the first quarter.
Darren Incorvaia
May 7, 2025 11:14am
NIH announces new office, plan to shift away from animal models
Apr 30, 2025 5:00pm
Chinese CRO expands in US as industry weighs FDA animal shift
Apr 20, 2025 2:50pm
FDA plans to end animal testing for new monoclonal antibody INDs
Apr 11, 2025 1:22pm
Regulation concerns keep non-animal models out of R&D: survey
Jul 18, 2024 6:30am
Charles River to develop animal-free inhalation toxicology tests
Jun 11, 2024 8:00am
